Bristol-Myers Squibb Company (BMY)

BMY (NYSE:Drugs) EQUITY
$67.48
pos +0.00
+0.00%
Today's Range: 67.34 - 68.08 | BMY Avg Daily Volume: 6,750,100
Last Update: 07/02/15 - 4:02 PM EDT
Volume: 0
YTD Performance: 14.31%
Open: $0.00
Previous Close: $67.67
52 Week Range: $47.34 - $69.86
Oustanding Shares: 1,666,974,545
Market Cap: 112,487,442,297
6-Month Chart
TheStreet Ratings Grade for BMY
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 8 8 8 8
Moderate Buy 1 1 1 0
Hold 4 4 4 7
Moderate Sell 0 0 0 0
Strong Sell 2 1 1 1
Mean Rec. 2.10 1.89 1.89 2.13
Latest Dividend: 0.37
Latest Dividend Yield: 2.19%
Dividend Ex-Date: 07/01/15
Price Earnings Ratio: 49.99
Price Earnings Comparisons:
BMY Sector Avg. S&P 500
49.99 50.20 26.10
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
6.72% 39.88% 87.18%
GROWTH 12 Mo 3 Yr CAGR
Revenue -3.10 -0.25 -0.09
Net Income -21.40 -0.61 -0.27
EPS -22.20 -0.44 -0.18
Earnings for BMY:
EBITDA 3.06B
Revenue 15.88B
Average Earnings Estimates
Qtr (06/15) Qtr (09/15) FY (12/15) FY (12/16)
Average Estimate $0.34 $0.36 $1.73 $2.27
Number of Analysts 9 8 13 13
High Estimate $0.38 $0.42 $1.86 $2.54
Low Estimate $0.30 $0.28 $1.64 $2.05
Prior Year $0.48 $0.45 $1.85 $1.73
Growth Rate (Year over Year) -29.86% -19.17% -6.40% 31.01%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Robert Moreno

 | Jul 2, 2015 | 12:45 PM EDT

Stock is showing short-term positive price momentum.

By

Roger Arnold

 | Jun 25, 2015 | 1:46 PM EDT

As health-care stocks rally, it's time for politicians to move on.

By

Paul Price

 | Jun 23, 2015 | 8:30 AM EDT

Company behind Enfamil could satisfy your appetite for gains.

By

Jim Cramer

 | Jun 22, 2015 | 2:04 PM EDT

Don't rely on Europe; it's too out of sync with U.S.

By

Sebastian Silva

 | Jun 17, 2015 | 3:10 PM EDT

Jim Cramer recently shared his insight on some of the best potential takeover targets, and we're taking his lead and looking at how his picks...

By

Jim Cramer

 | Jun 16, 2015 | 2:10 PM EDT

All would produce higher prices for the acquirers.

updateGoldman Healthcare Conf.

Jun 9, 2015 | 6:52 AM EDT

Goldman Sachs Healthcare Conference (Day 1 of 3) - 06/09/15 - 06/11/15 Los Angeles, CA

By

David Peltier

 | May 29, 2015 | 4:38 PM EDT

Lots of economic reports may affect stocks next week.

By

Jim Cramer

 | May 18, 2015 | 8:16 AM EDT

You could throw darts at financials and health care and win. 

By

Gary Morrow

 | May 11, 2015 | 2:48 PM EDT

The stock is extending Friday's breakout move.

So, why did the markets really get pasted on Monday? I believe it had more to do with the...
Aetna (AET) is paying .8375 shares plus $125 cash for Humana (HUM). This along with Cigna ...
"Ain't no time to hate, barely time to wait, Wo, oh, what I want to know, where does the t...
Sorry folks. I received a few queries concerning my earlier note on IMF nullification of t...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.